CIMAvax EGF: Clinical Trials

4 trials of CIMAvax EGF, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 active not recruiting, 1 completed, 1 not yet recruiting. 2 Early Phase 1, 2 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Early Phase 12Active not recruiting 1, Completed 1
Phase 22Active not recruiting 1, Not yet recruiting 1
Phase 11Active not recruiting 1

Follow CIMAvax EGF: new trials by email Literature Review of CIMAvax EGF trials Research Report on CIMAvax EGF

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
CIMAvax-EGF With KRAS G12C Inhibitor for the Treatment of Advanced, KRAS G12C Mutated Non Small Cell Lung Cancer
Adagrasib, Biospecimen Collection, Computed Tomography - Advanced Lung Non-Small Cell Carcinoma, Stage III Lung Cancer AJCC v8
Phase 2Not yet recruitingRoswell Park Cancer Institute292026-10-152026-09-02
EGF-Depleting Therapy CIMAvax-EGF in Combination With Standard Therapy for RAS- and BRAF Wild-Type Metastatic Colorectal Cancer
Recombinant Human EGF-rP64K/Montanide ISA 51 Vaccine, Leucovorin, Oxaliplatin - Colo-rectal Cancer
Early Phase 1Active not recruitingRoswell Park Cancer Institute22023-12-182026-08-21
A Vaccine (CIMAvax-EGF) for the Prevention of Lung Cancer Development or Recurrence
Quality-of-Life Assessment, Questionnaire Administration, Recombinant Human EGF-rP64K/Montanide ISA 51 Vaccine - Chronic Obstructive Pulmonary Disease, Lung Non-Small Cell Carcinoma
Early Phase 1CompletedRoswell Park Cancer Institute202021-11-222026-03-17
CIMAvax Vaccine, Nivolumab, and Pembrolizumab in Treating Patients With Advanced Non-small Cell Lung Cancer or Squamous Head and Neck Cancer
Laboratory Biomarker Analysis, Nivolumab, Pembrolizumab - Advanced Head and Neck Squamous Cell Carcinoma, Lung Non-Small Cell Carcinoma
Phase 1 / Phase 2Active not recruitingRoswell Park Cancer Institute512016-12-222026-08-10

Conditions studied

Lung Neoplasms (3)  ·  Carcinoma, Non-Small-Cell Lung (2)  ·  Colonic Neoplasms (1)  ·  Pneumonia (1)  ·  Pulmonary Disease, Chronic Obstructive (1)  ·  Squamous Cell Carcinoma of Head and Neck (1)

Sponsors

Roswell Park Cancer Institute (4)

Countries

United States (4)

Top investigators

Anuradha Krishnamurthy, MBBS (1)  ·  Grace K Dy (1)  ·  Mary Reid, PhD (1)  ·  Prantesh Jain, MD (1)